Zion Market Research Global Clinical Trial Imaging Market, 2016-2024 | Page 3

Clinical Trial Imaging Market
growth. The use of clinical trial imaging systems in the medical devices market boosts the
growth of the global market. The stringent government regulations regarding the product
development and its impact and the high cost of the imaging systems restrain the growth of
global clinical trial imaging market.
Global Clinical Trial Imaging Market: Segmentation
The global clinical trial imaging market is bifurcated based on the modality, product and
services, and end user. The modality segment is divided into X-ray, computed tomography,
positron emission tomography, magnetic resonance imaging, echocardiography, ultrasound,
dual-energy X-ray absorptiometry, and magnetic resonance elastography. The product and
service segment is categorized into software and services. The end user segment is further
classified into academic and government research institutes, medical device manufactures
pharmaceutical companies, biotechnology companies, contract research organizations, and
cosmetics and skin care industries.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/clinical-trial-imaging-market
Global Clinical Trial Imaging Market: Regional Analysis
North America is expected to dominate the global clinical trial imaging market. This market
is mainly driven by the huge R&D expenditure, rising number of CROs, and increasing
number of pharmaceutical and biotechnology companies. Asian market also attributes to the
global market growth due to the growing industrialization, urbanization, and high per capita
income. The emerging markets in the Asian region such as India, China, and Japan are
profitable for global clinical trial imaging market.